Investors having Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:A000250) on their watchlists might want to take into consideration the Gross Margin Score of the firm. Sam Chun Dang Pharm. Co., Ltd currently has a score of 11.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative. The low score of 11.00000 for Sam Chun Dang Pharm. Co., Ltd indicates a top score for stability and growth.
At the time of writing, Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:A000250) has a Piotroski F-Score of 3. The F-Score may help discover companies with strengthening balance sheets. The score may also be used to spot the weak performers. Joseph Piotroski developed the F-Score which employs nine different variables based on the company financial statement. A single point is assigned to each test that a stock passes. Typically, a stock scoring an 8 or 9 would be seen as strong. On the other end, a stock with a score from 0-2 would be viewed as weak.
Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:A000250) has a current ERP5 Rank of 3061 . The ERP5 Rank may assist investors with spotting companies that are undervalued. This ranking uses four ratios. These ratios are Earnings Yield, ROIC, Price to Book, and 5 year average ROIC. When looking at the ERP5 ranking, it is generally considered the lower the value, the better.
Shifting gears, we can see that Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:A000250) has a Q.i. Value of 21.00000. The Q.i. Value ranks companies using four ratios. These ratios consist of EBITDA Yield, FCF Yield, Liquidity, and Earnings Yield. The purpose of the Q.i. Value is to help identify companies that are the most undervalued. Typically, the lower the value, the more undervalued the company tends to be.
Checking in on some valuation rankings, Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:A000250) has a Value Composite score of 40. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales. The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 49.
Free Cash Flow Growth (FCF Growth) is the free cash flow of the current year minus the free cash flow from the previous year, divided by last year’s free cash flow. The FCF Growth of Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:A000250) is 1.554126. Free cash flow (FCF) is the cash produced by the company minus capital expenditure. This cash is what a company uses to meet its financial obligations, such as making payments on debt or to pay out dividends. The Free Cash Flow Score (FCF Score) is a helpful tool in calculating the free cash flow growth with free cash flow stability – this gives investors the overall quality of the free cash flow. The FCF Score of Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:A000250) is 1.677607. Experts say the higher the value, the better, as it means that the free cash flow is high, or the variability of free cash flow is low or both.
The Price Index is a ratio that indicates the return of a share price over a past period. The price index of Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:A000250) for last month was 1.11905. This is calculated by taking the current share price and dividing by the share price one month ago. If the ratio is greater than 1, then that means there has been an increase in price over the month. If the ratio is less than 1, then we can determine that there has been a decrease in price. Similarly, investors look up the share price over 12 month periods. The Price Index 12m for Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:A000250) is 1.47704.
Price Range 52 Weeks
Some of the best financial predictions are formed by using a variety of financial tools. The Price Range 52 Weeks is one of the tools that investors use to determine the lowest and highest price at which a stock has traded in the previous 52 weeks. The Price Range of Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:A000250) over the past 52 weeks is 0.868000. The 52-week range can be found in the stock’s quote summary.
C Score (Montier)
The C-Score is a system developed by James Montier that helps determine whether a company is involved in falsifying their financial statements. The C-Score is calculated by a variety of items, including a growing difference in net income verse cash flow, increasing days outstanding, growing days sales of inventory, increasing assets to sales, declines in depreciation, and high total asset growth. The C-Score of Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:A000250) is 3.00000. The score ranges on a scale of -1 to 6. If the score is -1, then there is not enough information to determine the C-Score. If the number is at zero (0) then there is no evidence of fraudulent book cooking, whereas a number of 6 indicates a high likelihood of fraudulent activity. The C-Score assists investors in assessing the likelihood of a company cheating in the books.